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SUMMARY Objective: To evolve simple methods for the assay of ofloxacin in biological fluids.
Methods: Simple methods for the estimation of ofloxacin in plasma, saliva and urine employing micro-
biological assay using plate diffusion technique and by fluorimetric method based on the measurement
of native fluorescence emitted by ofloxacin, have been described.
Results: The recovery of ofloxacin from all the three biologial fluids was 93-98% and the sensitivity was
0.5 µg/ml on all 5 different occasions by both the methods. Anti-TB drugs viz., rifampicin, ethambutol,
isoniazid and pyrazinamide and also anti-leprosy drugs viz., dapsone and clofazimine at concentrations
of 10 and 20 µg/ml did not interfere with the estimation of ofloxacin by either method. Ofloxacin is stable
in biological fluids for a period of at least 8 days at -20°C.
Conclusion: Both the methods described are simple, involve very few steps and do not need either
costly chemicals or sophisticated equipments.
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INTRODUCTION
Ofloxacin is a synthetic fluorinated carboxy quinolone
which is reported to have a broad antimicrobial spec-
trum1-4. Pharmacological studies of ofloxacin require
sensitive and specific methods for the estimation of
the drug in biological fluids such as blood, saliva and
urine. HPLC methods using fluorescence detector5,6
are available but they involve a series of steps for
preparation of the sample before analysis. More over,
all laboratories cannot afford to have such a sophisti-
cated equipment. Since E. coli is sensitive to ofloxacin,
we used it as test organism for the microbiological
assay. The zone of inhibition exhibited by ofloxacin
against E.coli is proportional to the concentration of
the drug present. Ofloxacin, by nature is fluorescent
and that the intensity of its native fluorescence de-
pends on the amount of the drug.
Making use of the above two properties of ofloxacin,
we have standardised the estimation of the drug in
plasma, saliva and urine by microbiological and
fluorimetric methods. The degree of interference, if
any, of certain anti-TB and anti-leprosy drugs in these
methods and the stability of ofloxacin in blood, saliva
and urine upon storage over a period of time were
also studied.
MATERIALS AND METHODS
Pure rifampicin, pyrazinamide, ethambutol and
ofloxacin from Sigma Chemical Company, pure iso-
niazid from May & Baker Ltd., nutrient agar (ingredi-
ents per litre are beef extract 3g, peptone 5g, agar
15g) and nutrient broth (ingredients per litre are beef
extract 3g, peptone 5g) from DIFCO, were used. All
other chemicals used were of analytical grade. The
strain of E.coli used was a clinical isolate.
Estimation of ofloxacin in plasma, saliva and urine
Microbiological assay: E.coli cultures were main-
tained in nutrient broth. Stock cultures of E.Coli from
the clinical isolates were maintained on nutrient agar
plates and stored at 4°C. Before each assay run, the
organism was sub-cultured onto nutrient broth. At
least two transfers in nutrient broth were made be-
fore the test assay. The nutrient broth cultures were
kept at 37°C for 24 h. On the day of the assay, turbid-
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Table 1. Serial ofloxacin concentrations by microbiological
method
Concen-
tration of
ofloxacin
(µg/ml)
0.5
1.0
2.0
4.0
8.0
18.0
zone of inhibition* of
E.coli against ofloxacin in
Plasma Saliva Urine
(mm) (mm) (mm)
5.82 5.40 4.89
7.44 7.28 6.69
9.17 9.15 8.92
10.98 10.78 10.73
12.33 12.42 12.20
14.04 14.05 13.94
Table 2. Serial ofloxacin concentrations by fluorimetric method
Concen- Fluorescence units* of ofloxacin in
tration of
ofloxacin
(µg/ml) Plasma Saliva Urine
0.5 30.10 32.10 25.40
1.0 64.20 63.30 55.90
2.0 120.90 127.10 109.80
4.0 252.00 257.00 220.80
8.0 501.40 507.00 436.20
16.0 974.90 971.00 849.70
* Values are the results of 5 different occasions (mean ± SD) and *Values are the results of 5 different occasions (mean ± S.D) and
the samples on each occasion in duplicate (n=10) the samples on each occasion in duplicate (n=10)
ity measurement of the broth culture was done at
630nm in a spectrophotometer. Only those cultures
which showed an optical density ranging from 0.275
to 0.325 were used.
Nutrient agar (11.5gm) was dissolved in 500ml of dis-
tilled water and pH adjusted to 7.0 using 0.4N sodium
hydroxide solution. The nutrient agar solution was
auto-claved for 20 min. at 15 Ibs. pressure. The agar
solution was then brought to 37 °C to 40 °C and the
organism kept in nutrient broth was seeded (0.4ml
culture/500ml solution). This was then poured into ster-
ile petri plates. Wells of 2mm diameter were cut.
A 1 mg/ml stock solution of ofloxacin was prepared by
dissolving it in a minimal amount of sterile 0.1N hy-
drochloric acid solution (0.2ml acid/10mg. ofloxacin).
Ofloxacin in concen trations of 0, 0.5, 1.0, 2.0, 4.0,
8.0 and 16.0 µg/ml in pooled plasma, saliva and urine
was set up in quadruplicate. Ten microlitres of the
standard solutions were loaded onto the wells.
The plates were incubated at 37°C for 24h. The zone
of inhibition was measured and its diameter was
found to be proportional to the amount of drug. The
concentration of the drug in unknown samples can
be calculated from the regression line of the log con-
centration of the standard and the diameter of the
zone of inhibition.
Fluorimetric method: One millilitre of plasma, sa-
liva or urine containing ofloxacin ranging from
0.5-16.0µg/ml was deproteinised with 1.O ml. of 0.7M
perchloric acid. The contents were centrifuged at
2500 rpm for 30 minutes. The resulting protein free
filtrate containing ofloxacin was read in a Perkin Elmer
LS 2B filter fluorimeter with an excitation wavelength
at 310 nm and an emission wavelength at 510 nm.
The relationship between ofloxacin concentration and
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the fluorescence units was linear. The concentration repeated on five different occasions.
of ofloxacin in unknown samples can be calculated
using a set of standard solutions containing known
concentrations of the drug.
Aqueous solutions containing the same concentra-
tions of ofloxacin were processed simultaneously to
check for recovery of the drug from plasma, urine
and saliva.
The assays were undertaken on five different occa-
sions after coding the samples independently for both
methods.
Interference of anti-TB and anti-leprosy drugs: On
each of 3 occasions, the interference of anti-TB drugs
like rifampicin, ethambutol, isoniazid and pyrazina-
mide and anti-leprosy drugs like dapsone and
clofazimine in the assay of ofloxacin by both the meth-
ods was tested individually. These drugs in concen-
trations of 10 and 20 µg/ml were added to ofloxacin
concentrations of 0, 0.5, 1.0, 2.0, 4.0, 8.0 and 16.0
µg/ml set up in quadruplicate and in duplicate for
microbiological and fluorimetric methods respectively,
in pooled plasma.
The fluorescent units were proportional to the con-
centration of ofloxacin employed and the recoveries
were also quantitative (95-97%) for all the three bio-
logical fluids when compared with water standards.
The co-efficients of variation for replicate estimations
for a concentration of 0.5 µg/ml were 9.0, 11.7 and
7.5 % and 1.4, 0.7 and 4.3 % for a concentration of
16.0 µg/ml with plasma, saliva and urine respectively.
The intraassay variations obtained for the three bio-
logical fluids by the fluorimetric method on five occa-
sions tested were almost same.
These results indicate that with ofloxacin, Beer’s law
is followed over the range 0.5-16.0 µg/ml in all the
three biological fluids by the fluorimetric method.
The fluorescent units obtained with plasma, saliva and
urine blanks were 9, 13 and 116 respectively com-
pared to a reading of 3 for water blank. This suggests
that it is essential to employ pooled plasma, saliva
and urine blanks for estimating ofloxacin concentra-
tions in the corresponding samples.
Stability of ofloxacin: Blood, saliva and urine were
collected from 2 patients after administration of 300
mg of ofloxacin. Plasma was separated and aliquots
of plasma, saliva and urine were stored at -20°C.
Ofloxacin was estimated by microbiological method
on days 0, 1, 3, 6 and 8.
RESULTS
Sensitivity: Sensitivity of the method has been re-
garded as the lowest concentration where the co-
efficient of variation for replicate estimations is 10 to
15 percent. In the estimation of ofloxacin by the micro-
biological method, the lowest concentration with which
the zone of inhibition could be read is 0.5 µg/ml. In
the case of fluorimetric method, the co-efficients of
variation obtained for plasma, saliva and urine at a
concentration of 0.25 µg/ml were 15.5, 17.3 and 15.4
Recovery of ofloxacin from plasma, saliva and
% respectively, at a concentration of 0.5 µg/ml, the
urine: The mean zones of inhibition and the mean fluo-
co-eff icients of variation were 9.0, 11.7 and 7.5 %
rescence units obtained with plasma, saliva and urine
which is lower than those obtained with 0.25 µg/ml.
are presented in Tables 1 and 2 respectively.
The sensitivity of both the methods is, therefore, 0.5
µg/ml.
Results showed that with the microbiological assay,
the zones of inhibition increased with increasing con-
centrations of ofloxacin over the range tested. Com-
parison of plasma, saliva and urine standards with
aqueous standards processed similarly showed that
recoveries of ofloxacin were quantitative (93-98%).
The co-efficients of variation for replicate estima-
tions were 10.4, 11.2 and 13.3 % for a concentration
of 0.5 µg/ml and 4.9, 5.7 and 4.3 % for a concentra-
tion of 16.0 µg/ml with plasma, saliva and urine re-
spectively. Similar co-efficients of variation were
obtained for all the three biological fluids when
Interference of anti-TB and anti-leprosy drugs:
The zones of inhibition for the microbiological method
and the fluorescence units for the fluorimetric method
were determined after randomisation of the speci-
mens. Results indicated that none of the drugs inter-
fered in the estimation of ofloxacin by both the meth-
ods.
Stability of ofloxacin: Results of the stability experi-
ments have shown that samples containing ofloxacin
can be stored upto 8 days at -20° C before the assay
is undertaken. (Table 3)
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Table 3. Stability of ofloxacin
Ofloxacin (µg/ml)
Day Plasma Saliva Urine
1 2 1 2 1 2
0 7.44 0.91 3.98 0.89 195.41 108.40
1 8.14 1.48 4.64 0.86 219.79 147.46
3 6.28 0.91 5.74 0.83 251.11 133.90
6 8.44 0.84 5.41 0.74 201.47 120.92
8 8.70 0.97 4.57 0.78 192.95 103.02
Other anti-TB and anti-leprosy drugs do not interfere
in the estimation of ofloxacin by both the methods. It
is, therefore, not necessary to withhold any drugs
when pharmacological investigations with ofloxacin
are carried out. The two methods, can thus be used
to estimate ofloxacin, even when the latter is given in
combination with other drugs. Ofloxacin is quite sta-
ble in plasma, saliva and urine upto a period of 8 days
when stored at -20 °C.
The authors are thankful to Mr. M. Kasinathan and
Mr. R. Karthigayan for their secretarial assistance.
Note: 1 & 2 indicate patients from whom samples were col-
lected after drug administration.
DISCUSSION 1.
The methods described here for the estimation of
ofloxacin in plasma, saliva and urine are fairly simple
and specific. Although the fluorimetric method is less
time consuming (i.e., the results will be available within
2 hours), the volume of test sample required is 0.5 ml
(500 µl). On the other hand, with the microbiological
method, although the volume of the test sample re-
quired is only 10 - 50 µl, the results will be available
only after 24 hours. Depending upon the volume of
the sample available, any one of the two methods
can be chosen. The sensitivity by both the methods
is 0.5 µg/ml for the estimation of ofloxacin in either
plasma, saliva or urine but this is not a serious limita-
tion as this concentration is well below the minimal
inhibitory concentration of 2.0 µg/ml in L.J. medium7.
2.
3.
4.
5.
In the estimation of ofloxacin reported here, urine
blanks gave higher fluorescence units than plasma
or saliva blanks. However, this higher fluorescence in
the urine blank, does not have any quenching effect
when pooled urine containing varying concentrations
of ofloxacin were estimated. There was linearity in
the fluorescence units in relation to varying concen-
trations tested in urine.
6.
7.
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